Summary of Key Points
The report in "Economic Observer" regarding the alleged harm of formaldehyde in diapers to infants and young children has sparked two major controversies: first, the credibility of the blood test methods and results for detecting formaldehyde; second, whether the source of the blood samples from infants and young children violates research ethics. The article analyzes that if the blood samples come from leftover clinical test specimens from hospitals, it is unlikely to violate ethics (as the standard informed consent procedures already cover the use of such residual samples for research purposes), but the details of the ethical assessment and privacy protection need to be verified. However, there are scientific flaws in the testing process itself (such as blood collection methods and sample preservation), which may render the results unreliable.
Ethical Controversy over Blood Sample Sources: Is It Ethical to Use Residual Samples for Research?
Many people wonder whether parents are aware that so many blood samples from infants under one year old are being used for research. The key point here is that these samples were not collected specifically for research purposes but are leftovers from routine medical examinations. For example, when you take your child to the hospital for a blood test, only a small portion of the blood drawn (perhaps 1/10) is actually used for testing, with the remaining sample being classified as "residual."
According to industry standards, hospital informed consent forms typically state that "residual samples can be used for research" (without the need for additional parental consent). Therefore, in principle, using these residual samples for research does not violate ethics. However, two prerequisites must be met: ① The research institution must conduct an ethical assessment to determine the necessity and potential harm of the research; ② Privacy must be protected (samples must be anonymized to prevent the disclosure of children's information). If either of these conditions is not met, it constitutes a violation.
Are the Test Results Reliable? Two Doubts Raise Questions
Even if the source of the blood samples is legitimate, there are significant issues with the testing process:
1. Blood Collection Methods: It is difficult to draw venous blood from infants and young children due to their small blood vessels. If capillary blood sampling is used, the amount of blood collected is very limited (possibly just a few drops). With such a small sample volume, the reliability of the formaldehyde test results is questionable even for experts.
2. Sample Preservation: How are the residual samples stored? For how long? Are the storage conditions consistent across all samples? For instance, if some samples are refrigerated while others are left at room temperature for several days, the formaldehyde content may change, making the results unreliable.
Additionally, although the report mentions "hundreds of samples," the provided table only shows data for about 30 samples, which raises further doubts about the credibility of the findings.
What Will the Joint Investigation Team Investigate?
The multi-departmental investigation will focus on the following aspects:
- Ethical Assessment: Has the Shandong Public Health Clinical Research Center conducted a formal ethical review for this formaldehyde testing project?
- Privacy Protection: Have the samples been anonymized? Were any samples containing children's personal information sent to third-party laboratories for testing?
- Sample Details: Were the blood samples collected from capillaries or veins? Are the storage times and conditions consistent across all samples?
By clarifying these details, it will be possible to determine whether the claims about "hundreds of test reports" are accurate.
Conclusion: Ethics May Not Be at Fault, but There Could Be Serious Scientific Issues
The article concludes that, while the ethical use of residual samples may not be problematic (assuming the relevant regulations are followed), there are significant scientific flaws in the research methodology—non-standard blood collection methods, inconsistent sample preservation practices, and discrepancies in the number of samples—all of which undermine the credibility of the test results. In short, "the source of the blood samples may be legal, but the test results could be incorrect."
This highlights the importance of examining the testing methods and sample sources when reviewing reports claiming to reveal health hazards. After all, scientific conclusions must be supported by evidence and cannot rely solely on sensational claims.